Dr Michael Winlo - CEO & Managing Director - Emyria Limited (ASX:EMD) is evaluating MDMA-assisted therapy for post-traumatic stress disorder. The company is also advancing the MDMA molecule itself and refining its interaction with primary neurotransmitters like serotonin and dopamine.